11q13 is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer

Research output: Contribution to journalJournal articlepeer-review

  • Diether Lambrechts
  • Therese Truong
  • Christina Justenhoven
  • Manjeet K Humphreys
  • Jean Wang
  • John L Hopper
  • Gillian S Dite
  • Carmel Apicella
  • Melissa C Southey
  • Marjanka K Schmidt
  • Annegien Broeks
  • Sten Cornelissen
  • Richard van Hien
  • Elinor Sawyer
  • Ian Tomlinson
  • Michael Kerin
  • Nicola Miller
  • Roger L Milne
  • M Pilar Zamora
  • José Ignacio Arias Pérez
  • Javier Benítez
  • Ute Hamann
  • Yon-Dschun Ko
  • Thomas Brüning
  • Jenny Chang-Claude
  • Ursel Eilber
  • Rebecca Hein
  • Stefan Nickels
  • Dieter Flesch-Janys
  • Shan Wang-Gohrke
  • Esther M John
  • Alexander Miron
  • Robert Winqvist
  • Katri Pylkäs
  • Arja Jukkola-Vuorinen
  • Mervi Grip
  • Georgia Chenevix-Trench
  • Jonathan Beesley
  • Xiaoqing Chen
  • Florence Menegaux
  • Emilie Cordina-Duverger
  • Chen-Yang Shen
  • Jyh-Cherng Yu
  • Pei-Ei Wu
  • Ming-Feng Hou
  • Irene L Andrulis
  • Teresa Selander
  • Nordestgaard, Børge
  • Bojesen, Stig Egil
  • Charlotte Lanng
  • The GENICA Network
A recent two-stage genome-wide association study (GWAS) identified five novel breast cancer susceptibility loci on chromosomes 9, 10 and 11. To provide more reliable estimates of the relative risk associated with these loci and investigate possible heterogeneity by subtype of breast cancer, we genotyped the variants rs2380205, rs1011970, rs704010, rs614367, rs10995190 in 39 studies from the Breast Cancer Association Consortium (BCAC), involving 49,608 cases and 48,772 controls of predominantly European ancestry. Four of the variants showed clear evidence of association (P = 3 × 10-9) and weak evidence was observed for rs2380205 (P = 0.06). The strongest evidence was obtained for rs614367, located on 11q13 (per-allele odds ratio 1.21, P = 4 × 10-39). The association for rs614367 was specific to estrogen receptor (ER)-positive disease and strongest for ER plus progesterone receptor (PR)-positive breast cancer, whereas the associations for the other three loci did not differ by tumor subtype.
Original languageEnglish
JournalHuman Mutation
ISSN1059-7794
DOIs
Publication statusPublished - 2012

ID: 40173958